Physician profile
Prasanth Katta
NPI 1720493877
$18,980.63
in general payments reported to CMS, 2019-2025
22 companies · $4,270 in 2025
The $4,270 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,351 · 2020: $840 · 2021: $1,793 · 2022: $2,721 · 2023: $1,394 · 2024: $2,610 · 2025: $4,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,952 · Travel and Lodging: $2,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,951.65 |
| Travel and Lodging | $2,323.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,190.80 | 2019-2025 | Eterna, Proclaim |
| Medtronic USA, INC. | $3,704.98 | 2019-2020 | |
| Medtronic, INC. | $2,386.33 | 2021-2025 | Intellis Adaptivestim, Osteocool Rf Ablation System |
| Spinal Simplicity, LLC | $1,738.79 | 2024-2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $1,698.22 | 2019-2025 | General - Pain Management, General - Therapies, Intracept Rf Probe |
| Si-Bone, INC. | $1,335.92 | 2024 | |
| Nevro Corp. | $833.76 | 2019-2023 | Senza |
| Spr Therapeutics, INC | $439.85 | 2022-2025 | Sprint Pns System |
| Biotronik Nro, INC. | $410.17 | 2025 | Prospera |
| Painteq LLC | $302.16 | 2021-2022 | |
| Globus Medical, INC. | $183.79 | 2025 | Vyrsa V1 |
| Stryker Corporation | $176.02 | 2022-2025 | Mild Device Kit, Multigen 2 |
| Nalu Medical, INC. | $139.61 | 2023 | Nalu Neurostimulation System |
| Alexion Pharmaceuticals, INC. | $117.76 | 2021 | |
| Janssen Pharmaceuticals, INC | $89.49 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $78.70 | 2025 | Reactiv8 |
| Catalyst Orthoscience | $37.09 | 2024 | Catalyst Csr Shoulder System |
| Ferring Pharmaceuticals INC. | $35.25 | 2020-2025 | Euflexxa |
| Avanos Medical | $24.38 | 2020 | |
| Vertos Medical, INC. | $23.74 | 2022 | |
| Abbvie INC. | $17.89 | 2022 | |
| Foundation Fusion Solutions, LLC | $15.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prasanth Katta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.